News Releases

Date Title and Summary
Feb 03, 2022 Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2021 Financial Results
ATLANTA , Feb. 3, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that fourth quarter and full year 2021 financial results will be released on Thursday, February 17, 2022 after the market closes.  On that
Jan 31, 2022 Artivion Announces Publication of On-X® Mitral Heart Valve PROACT Study Results in The Annals of Thoracic Surgery
Results Presented at the 2022 Annual Meeting for The Society of Thoracic Surgeons ATLANTA, Jan. 31, 2022 /PRNewswire/ -- Artivion, Inc. (NYSE:  AORT ), a leading cardiac and vascular surgery company focused on aortic disease, today announced the publication of PROACT clinical trial results in  The
Jan 18, 2022 CryoLife Announces Corporate Rebranding and Changes Name to Artivion
Artivion to Host Investor & Analyst Day on March 23, 2022 ATLANTA , Jan. 18, 2022 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and rebranding itself to Artivion, Inc.
Displaying 21 - 23 of 23